From liver disease to diabetes, coffee compounds protect against an array of health conditions.
- Reduces liver fibrosis
- Slows heart and liver damage
- May counter Parkinson’s, dementia, depression
- Boosts feel-good dopamine
Polyphenols (chlorogenic acids, caffeic acid)
- Reduce liver fibrosis
- Boost DNA repair
- May fend off blood clots
- Boost metabolic efficiency
- Lower blood pressure (offsetting caffeine’s fleeting blood pressure–boosting effect)
- Act as demethylating agents
- Lessen intestinal injury from free radicals
Diterpenes (cafestol and kahweol)
- Fight certain carcinogens
- Reduce liver DNA adducts (bits of DNA bound to carcinogens)
- Boost levels of glutathione, an antioxidant that prevents liver damage
- Target and kill mesothelioma cells in lung tissues
- Kahweol is anti-inflammatory and cuts blood flow to tumors
- But both can also lead to higher levels of bad cholesterol (LDL)
- Lowers blood sugar
- May have brain benefits
To the liver rescue
Coffee’s most obvious benefits go to the liver, a big, busy organ. Nutrients get absorbed from food through the gastrointestinal tract and enter the blood. Those nutrients are metabolized in the liver — detox central — which regulates blood levels of fats and sugars.
Chronic liver disease affects up to 15 percent of the U.S. population. The liver is most often damaged by drinking excess alcohol, contracting hepatitis C virus or developing fatty liver disease, which is associated with obesity. Just as the skin forms patches of tough collagen protein over damaged areas, the liver does, too. Over time, this process can result in fibrous collagen scars, or fibrosis, which can disrupt blood flow through the liver. The risk is cirrhosis and, ultimately, liver failure, says Jonathan Dranoff, a gastroenterologist and hepatologist at the University of Arkansas for Medical Sciences in Little Rock.
That’s where coffee comes in. When the liver senses tissue damage, the compound adenosine binds to receptor proteins on the liver’s stellate cells. These make collagen to form fibrous scars. Caffeine binds to the adenosine receptors and interrupts the signaling process so that collagen isn’t mass-produced.
Caffeine tamps down collagen overproduction in a second way. It hits the enzyme alanine aminotransferase, which is implicated in fibrosis. People with liver disease who drink caffeinated coffee make less of the enzyme than minimal drinkers.
In a large U.S. study last year, people drinking two or more cups of decaf daily also suppressed the troublesome enzyme. Other studies suggest that certain polyphenols in coffee — found in decaf or regular — knock down that enzyme.
Coffee drinkers who have hepatitis C, a viral infection that can lead to liver fibrosis and cancer, show similar benefits. Of 177 liver disease patients, most with hepatitis C, those who drank more than two cups of caffeinated coffee per day were less likely than scant drinkers to have their fibrosis become severe, according to a study in Hepatology in 2010. Curiously, other sources of caffeine, such as energy drinks, didn’t provide a benefit.
Fatty liver disease, which is rising in tandem with obesity rates, may be susceptible to coffee as well. U.S. scientists identified 306 overweight people who hadn’t been diagnosed with liver disease. Ultrasound images and biopsies revealed 180 who had fat deposits in the liver, early signs of fibrosis. Based on those tests, coffee abstainers were moving faster toward fibrosis than consumers. People who had advanced-stage fatty liver averaged less than a cup a day of caffeinated coffee, compared with nearly two cups for those who were still at an early stage of the disease, a 2012 report in Hepatology noted.
Coffee shows a stunning effect against liver cancer. Earlier this year, a European team reported that women who drank two and a half or more cups and men who drank three and a half or more daily were 72 percent less likely to develop liver cancer than people who drank less than about one-third cup a day. The study included roughly half a million healthy people monitored for 11 years. During the study, 201 people developed liver cancer. The findings remained robust even when adjusted to account for hepatitis, the scientists reported in the April 15 International Journal of Cancer.
The liver cancer finding “is likely to be an extension of a possible protective effect of coffee on chronic liver disease,” says study coauthor Anna Flögel of the German Institute of Human Nutrition Potsdam-Rehbrücke in Nuthetal.
Some doctors are convinced. “Do I prescribe coffee to my patients?” Dranoff asks. “For those with chronic liver disease, the answer is yes.” In a 2014 review in Liver International, UCLA physician Sammy Saab and his colleagues stated that “daily coffee consumption should be encouraged” for patients with liver disease.
The diabetes defense
Coffee’s protective effect against type 2 diabetes came to light in 2002. In a study of healthy people, van Dam and his Dutch colleague Edith Feskens found that those who averaged a whopping seven cups a day were half as likely to develop diabetes over several years as those who got by on two or fewer cups a day. In this study of people ages 30 to 60, protection seemed to start at three cups a day and rise with intake.
That report, published in the Lancet, triggered dozens of studies seeking to replicate it, and many have. An international review of 28 studies, published in Diabetes Care in 2014, included more than 1 million healthy people monitored for 10 months to 20 years. About 45,000 developed type 2 diabetes while in a study. The likelihood of a diabetes diagnosis was 21 percent lower in people drinking three cups a day versus none. For those drinking six cups daily, risk was 33 percent lower. Regular or decaf didn’t matter.
Onset of type 2 diabetes is preceded by poor energy metabolism. Cells fail to take up glucose efficiently, leading to high blood sugar. Caffeine and the polyphenols called chlorogenic acids boost metabolic efficiency. When Australian scientists fed rats a high-fat, high-carbohydrate diet, the animals started to display inefficient energy metabolism, some fatty liver and even early signs of heart disease. Coffee extract including caffeine, chlorogenic acids and other components improved the animals’ ability to process glucose, lowered their blood pressure and slowed damage to the heart and liver. The report appeared in the Journal of Nutrition in 2012.
Of course, adding sugar detracts from coffee’s commendable effects. Milk has calcium and protein but dilutes the coffee.
In pursuit of the perfect cup
The global favorites among coffee beans are Arabica (Coffea arabica) and Robusta (Coffea canephora). Robusta has a more aggressive flavor, more caffeine and more of the beneficial polyphenols known as chlorogenic acids. The milder Arabica is more popular, but contains a bit more sugar and oil. Both Dunkin’ Donuts and Starbucks say they use it exclusively.
To brew a healthful cuppa joe, preparation method may be as important as bean choice. Roasting cooks some of the good-for-you chlorogenic acids right out of the beans, according to a 2013 report in Food Chemistry (see chart). Chock one up for blonde, or light, roasts.
Today’s popular drip filters remove cholesterol-raising oils from coffee. Boiled coffee and French press still let the oils through; espresso filters out only some. Espresso drinkers had poorer scores on HDL, the good cholesterol, and higher blood levels of triglycerides than filtered coffee drinkers in a study published in 2012. But filtering has its drawbacks, including loss of the cancer-fighting diterpenes.
As findings pour in, researchers try to define the perfect cup. “We’ve reached a funny intersection,” says Jonathan Dranoff, “between artisanship and health.”
Sources (graph): C.E. Mills et al/Food Chem. 2013; (chart): E. Mejia and M. Ramirez-Mares/Trends Endocrinol. Metab. 2014; J. Feld et al/F1000Research 2015; Beverage Institute; Mayo Clinic.
Under the microscope
Coffee’s cancer protection appears to extend beyond the liver, but to a more modest degree. For example, European women who drink three cups a day have a 19 percent lower risk of uterine cancer compared with scant drinkers, scientists reported in the February Cancer Epidemiology, Biomarkers & Prevention. Earlier, Japanese researchers found that coffee drinkers were slightly less apt to develop cancer of the mouth and throat than those who drank very little. Coffee also has exhibited potential against colon cancer, melanoma and breast cancer.
Population studies mean little without a biological explanation. For cancer, coffee has several candidates. Polyphenols in caf and decaf boost DNA-repair genes, an essential step in keeping cells from becoming cancerous. The main polyphenols, chlorogenic acids and caffeic acid (not related to caffeine), are demethylating agents, meaning they thwart the addition of methyl groups to DNA. Methylation can be a cancer trigger.
Coffee components called diterpenes may pitch in against cancer as well. In cell cultures and animal studies, two diterpenes called cafestol and kahweol inhibit certain carcinogens and reduce concentrations of liver DNA adducts (pieces of DNA bound to cancer-causing chemicals). Kahweol has anti-inflammatory effects and suppresses angiogenesis, the flurry of blood vessel growth that tumors need. As a bonus, both diterpenes boost levels of glutathione, a potent antioxidant that may prevent liver damage. In lab tests of human mesothelioma (a cancer of the lung’s lining that is often caused by asbestos exposure), diterpenes targeted and killed the cancer cells.
Meanwhile, chlorogenic acids and caffeic acid also act as antioxidants, adeptly scavenging harmful free radicals, Brazilian researchers reported in the Journal of Agricultural and Food Chemistry in May. In rat models of intestinal injury, chlorogenic acids and caffeic acid reduced damage from free radicals. In the intestines, coffee might also aid the growth of helpful Bifidobacteria, a British team has found. These natural gut dwellers have been used as probiotics to treat diarrhea and ulcerative colitis.
Trigonelline, yet another coffee component, seems to aid in the antidiabetes effect while also working as an antioxidant and benefiting the brain. More recently, scientists have become interested in a coffee chemical called hydroxyhydroquinone, or HHQ, which increases with the roasting process. The good news is that HHQ might have anticancer properties. The bad news is that it might suppress some effects of chlorogenic acids, specifically their ability to bring down blood pressure. Caffeic acid may enhance nitric oxide in the body, which makes blood vessels flexible and more easily dilated.
A reassuring cup or four
All these biological effects, however they work, might together hold off the reaper. The 2012 mortality study, which included more than 400,000 middle age and older people, found that coffee consumption was associated with a 6 to 16 percent reduction in death risk during the study, which ran from 1995 to 2008. It appeared in the New England Journal of Medicine.
Drinking three to four cups a day seemed optimal in a recent study of more than 90,000 people in Japan. Drinkers in that sweet spot were 24 percent less likely to die during the average follow-up of nearly 19 years than people who didn’t drink coffee, researchers reported in the American Journal of Clinical Nutrition in May.
“These studies provide some reassurance to regular coffee drinkers that this seems like a relatively safe behavior,” says Neal Freedman, a biochemist and epidemiologist at the National Cancer Institute who coauthored the 2012 study.
In earlier work, van Dam sought to establish safe upper limits for coffee intake. He and others found no added mortality risk among people who drink six cups a day.
Despite the flood of positive findings, some researchers can’t help but remain cautious. Klatsky offers an example, regarding the studies showing no link between atrial fibrillation and coffee, caffeinated or not. “People who get symptoms from coffee tend to stop drinking it,” he says. So the only coffee drinkers in some studies would be those who don’t feel any bad effects, a self-selected group. Other studies often failed to note the kind of coffee people drank, the degree of roasting or other details that can matter.
Nevertheless, coffee’s new status, as a pleasure without the guilt, might be reaching the mainstream. Every five years, a U.S. panel of experts reviews dietary guidelines and advises the federal government. Its February 2015 report found that drinking three to five cups of coffee a day carries no chronic disease risk. The report even notes apparent benefits against diabetes, heart disease and Parkinson’s disease.
“This is a kind of paradigm shift,” says Hu, a panel member. The scientists were cautious, he says, and concern remains that too much caffeine may not be good for kids. But in adults, the coffee picture is becoming clear.
“It’s not a panacea,” Hu says. “It’s just a drinking habit that may confer health benefits.”
Coffee — it does a body good
The brew shows promise against an array of ailments:
Parkinson’s. In a prospective study, people who drank about four cups of caffeinated coffee daily were one-fourth less likely to develop Parkinson’s disease than those who drank very little, researchers reported in the American Journal of Epidemiology in 2012. Parkinson’s involves a loss of dopamine, a hormone that is necessary for motor skills. In the brain, caffeine elevates dopamine levels, possibly explaining how coffee helps against Parkinson’s and suggesting why coffee has addictive effects.
Dementia. In a 2012 study, researchers monitored 32 older people with mild cognitive impairment. Caffeine levels (largely from coffee) in blood samples were lower by half at the outset in individuals who later progressed to dementia than in those who didn’t, scientists reported in the Journal of Alzheimer’s Disease. While coffee contains more caffeine than most other popular drinks, polyphenols in coffee may help memory, too.
Depression. In a 10-year study of 50,000 U.S. women, those drinking two to three cups of caffeinated coffee a day were 15 percent less likely to have depression than those consuming little. Women who drank four or more cups a day had a 20 percent lower risk, researchers reported in Archives of Internal Medicine in 2011. Suicide risk also falls with caffeinated coffee consumption.
Blood pressure. The caffeine in coffee boosts heart rate and short-term blood pressure, but these effects don’t appear to linger. In a 2011 analysis of six studies involving more than 170,000 adults, researchers found hints that two or three cups a day increased hypertension risk slightly, but the risk disappeared in people who drank even more coffee. The researchers speculate that other coffee components — chlorogenic acids, magnesium and potassium, which lowers blood pressure — might offset a caffeine effect. Or people may build up tolerance to caffeine.
Heart disease and stroke. Demographic studies suggest coffee offers modest protection against heart disease. Polyphenols in coffee might also fend off blood clots. Mice given oral chlorogenic acids or caffeic acid had less of a protein linked to platelets and clotting. In people, coffee drinkers were 29 percent less likely to have a stroke as coffee avoiders, a 2010 study found.
Kidney function. Nineteen healthy 20-somethings were assigned to drink three cups of coffee daily for two weeks, then switch to green tea, or vice versa. Blood measures of kidney filtration efficiency, in which lower denotes better, fell by 4.8 percent after the coffee stint but were unchanged after green tea, Japanese researchers reported in 2011 in the Journal of Nutrition and Metabolism.
Originally Posted in Science News
N.D. Freedman et al. Association of coffee drinking with total and cause-specific mortality. New England Journal of Medicine. Vol. 366, May 17, 2012, p. 1891. doi: 10.1056/NEJMoa1112010.
C.E. Mills et al. The effect of processing on chlorogenic acid content of commercially available coffee. Food Chemistry. Vol. 141, December 15, 2013, p. 3335. doi:10.1016/j.foodchem.2013.06.014.
M. Ding et al. Coffee consumption and cardiovascular disease risk.Circulation. Published online November 7, 2013. doi: 10.1161/CIRCULATIONAHA.113.005925.
J.J. Feld et al. I drink for my liver, Doc: emerging evidence that coffee prevents
cirrhosis. F1000Research. Vol. 4, April 29, 2015, p. 95. doi: 10.12688/f1000research.6368.1.
R. Liu et al. Caffeine intake, smoking, and risk of Parkinson disease in men and women. American Journal of Epidemiology. Vol. 175, April 13, 2012, p. 1200. doi: 10.1093/aje/kwr451.
M. A. Merritt et al. Investigation of dietary factors and endometrial cancer risk using a nutrient-wide association study approach in the EPIC and Nurses’ Health Study (NHS) and NHSII.Cancer Epidemiology, Biomarkers & Prevention. Vol. 24, February 2015, p. 466. doi: 10.1158/1055-9965.EPI-14-0970.
J.W. Molloy et al. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology. Vol. 55, February 2012, p. 429. doi: 10.1002/hep.24731.
J.-K. Oh et al. Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. International Journal of Cancer. Vol. 137, October 15, 2015, p. 1979. doi: 10.1002/ijc.29569.
E. Lopez-Garcia et al. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. American Journal of Clinical Nutrition. Vol. 84, October 2006, p. 888.
A.E. Mesas et al. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: A systematic review and meta-analysis. American Journal of Clinical Nutrition. Vol. 94, October 2011, p. 1113. doi: 10.3945/ajcn.111.016667.
J. Kim et al. Association between coffee intake and gastroesophageal reflux disease: a meta-analysis. Diseases of the Esophagus. Publisged online June 24, 2013. doi: 10.1111/dote.12099.
F. Morisco et al. Coffee and liver health. Journal of Clinical Gastroenterology. Vol. 48, November/December 2014, p. S87. doi: 10.1097/MCG.0000000000000240.
I. Hečimović et al. Comparative study of polyphenols and caffeine in different coffee varieties affected by the degree of roasting.Food Chemistry. Vol. 129, 2011, p. 991. doi: 10.1016/j.foodchem.2011.05.059.
J.A. Dranoff et al. How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations.Hepatology. Vol. 60, August 2014, p. 464. doi: 1002/hep.27032.
H. Jick et al. Coffee and myocardial infarction. New England Journal of Medicine. Vol. 289, July 12, 1973, p. 63. doi: 10.1056/NEJM197307122890203.
M.P. Weusten-Van der Wouw et al. Identity of the cholesterol-raising factor from boiled coffee and its effects on the liver function enzymes. Journal of Lipid Research. Vo. 35, April 1994, p. 721.
E. Lopez-Garcia et al. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. American Journal of Clinical Nutrition. Vol. 84, October 2006, p. 888.
S.K. Panchal et al. Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in high-carbohydrate, high-fat diet-fed male rat. Journal of Nutrition. Vol. 142, April 1, 2012, p. 690. doi: 10.3945/jn.111.153577.
C. Cardenas, A.R. Quesada and M.A. Medina. Anti-Angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene.PLOS ONE. Vol. 6, August 2011, p. e23407. doi:10.1371/journal.pone.0023407.
S. Bidel et al. Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes.Diabetologia. Vol. 49, November 2006, p. 2618. doi 10.1007/s00125-006-0435-9.
E. Saito et al. Association of coffee intake with total and cause-specific mortality in a Japanese population: the Japan Public Health Center–based Prospective Study. American Journal of Clinical Nutrition. Published online March 11, 2015. doi: 10.3945/ajcn.114.104273.
E. Arnesen et al. The Tromsø Heart Study: Distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. Scandinavian Journal of Clinical and Laboratory Investigation. Vol. 46, January 1986, p. 63. doi: 10.3109/0036551860908648.
Z. Zhang et al. Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies. American Journal of Clinical Nutrition. Vol. 96, September 2012, p. 647. doi: 10.3945/ajcn.112.034413.
T. Shimamoto et al. No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: A cross-sectional study of 8,013 healthy subjects in Japan. PLOS ONE. Vol. 8, June 12, 2013, p. 65996. doi: 10.1371/journal.pone.0065996
A.L. Klatsky et al. Coffee, Caffeine, and Risk of Hospitalization for Arrhythmias. The Permanente Journal. Vol. 15, Summer 2011, p. 19.
S. Saab et al. Impact of coffee on liver diseases: a systematic review. Liver International. Vol. 34, April 2014, p. 495. doi: 10.1111/liv.12304.
A. A. Modi et al. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology. Vol. 51, January 10, 2010, p. 201. doi 10.1002/hep.23279.
C. Bamia et al. Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: Multicentre, prospective cohort study. International Journal of Cancer. Vol. 136, April 15, 2015, p. 1899. doi: 10.1002/ijc.29214.
C.E. Ruhl and J.E. Everhart. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology. Vol. 129, December 2005, p. 1928. doi: 10.1053/j.gastro.2005.08.056.
N.P. Rodrigues et al. Influence of coffee genotype on bioactive compounds and the in vitro capacity to scavenge reactive oxygen and nitrogen species. Journal of Agricultural and Food Chemistry. Vol. 63, May 6, 2015, p. 4815. doi: 10.1021/acs.jafc.5b00530.
Y. Zhao et al. Antihypertensive effects and mechanisms of chlorogenic acids. Hypertension Research. Vol. 35, April 2012, p. 370. doi: 10.1038/hr.2011.195.
M. Ding. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: A systematic review and a dose-response meta-analysis. Diabetes Care. Vol. 37, February 2014, p. 569. doi: 10.2337/dc13-1203.
R. van Dam and E. Feskens. Coffee consumption and risk of type 2 diabetes mellitus. Lancet. Vol. 360, November 9, 2002, p. 1477. doi:10.1016/S0140-6736(02)11436-X.
E. Loftfield et al. Abstract LB-280: Prospective study of coffee drinking and risk of melanoma in the United States. Cancer Research. Vol. 74, October 1, 2014, LB-280 AM2014-LB-280. doi: 10.1158/1538-7445.
K. Poikolainen and E. Vartiainen. Determinants of gamma-Glutamyltransferase: Positive interaction with alcohol and body mass index, negative association with coffee. American Journal of Epidemiology. Vol 146, June 1997, p. 1019.
M. Inoue et al. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiology, Biomarkers and Prevention. Vol. 18, June 2009, p. 1746. doi: 10.1158/1055-9965.EPI-08-0923.
I. Ludwig et al. Coffee: biochemistry and potential impact on health. Food & Function. Published online March 20, 2014, p. 1695. doi: 10.1039/C4FO00042K.